Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Views & Analysis Graph power: life sciences lead in intelligent data use Graph technology is allowing pharma to model data in a way that offers invaluable insights for marketing, R&D and compliance teams alike.
Views & Analysis Making data science a part of the life sciences sales strate... Since the dawn of the age of ‘big data’, the life sciences industry has seen exponential growth in the amount of customer data readily available – an amount that is set to continue to grow at a
Views & Analysis Impact of data management on clinical trials: new study The correlation between the upfront time to build and release a clinical database and its impact on downstream data management.
Views & Analysis Real-world data – optimising your strategy for market access... The points to consider in preparing an effective data strategy.
Views & Analysis Keeping ahead of the curve Jon Williams, President of Evidera, is well-placed to offer his views on the issues impacting access to therapies.
News Cash injection will help Varda make drugs in space A new US startup, called Varda Space Industries, has raised $187 million in financing for a bold plan to manufacture medicines in orbit.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
